BlackRock
CEREW

BlackRock’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

BlackRock’s Portfolio CEREW Stock Details CEREW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-236,914
Closed -$3.41M – 5754
2021
Q2 		$3.41M Hold
236,914
– – ﹤0.01% 4048
2021
Q1 		$1.02M Buy
236,914
+1
+0% +$5 ﹤0.01% 4495
2020
Q4 		$1.34M Buy
+236,913
New +$956K ﹤0.01% 4148

BlackRock's CEREW Position: Q3 2021 in Review

BlackRock sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 236,914 shares — an estimated $3.41M sold.

BlackRock first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $3.41M in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

  • BlackRock reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
  • BlackRock sold 236,914 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $3.41M.
  • BlackRock first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
  • BlackRock's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $3.41M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.